Search clinical trials for: 1.5 mg PF-06649751 21 Days

Total 129 results

Radiation Therapy Oncology Group
National Cancer Institute (NCI); NRG Oncology

Completed

Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme (RTOG 0913)

Brain and Central Nervous System Tumors

United States, Israel, Canada
University of Oxford
Mahidol University

Completed

Incidence of Vivax Along the Thai Burma Border (VHC)

Vivax Malaria

Thailand
Shanghai University of Traditional Chinese Medicine
Shanghai Chest Hospital

Unknown

Efficacy Study of Chinese Medicine Plus EGFR-TKI Versus EGFR-TKI in Advanced Pulmonary Adenocarcinoma

Cancer
Darnitsa Pharmaceutical Company
International Pharmaceutical Research Center

Completed

Bioequivalence Study of 8 mg Perindopril Tert-Butylamine / 2.5 mg Indapamide / 10 mg Amlodipine Tablets Versus 10 mg Perindopril Arginine / 2.5 mg Indapamide / 10 mg Amlodipine Film-Coated Tablets in Healthy Volunteers

Healthy Subjects | Bioequivalence

Jordan
FORUM Pharmaceuticals Inc
Syneos Health

Completed

Safety, Tolerability, and Pharmacokinetic Study of EVP-6124 in Patients With Alzheimer's Disease

Central Nervous System Diseases | Alzheimer's Disease

United States
FORUM Pharmaceuticals Inc

Completed

Safety, Tolerability, and Pharmacokinetic Study of EVP-6124 in Patients With Schizophrenia

Central Nervous System Diseases | Schizophrenia | Schizoaffective Disorder

United States
Center for International Blood and Marrow Transplant...
National Marrow Donor Program

Completed

HLA-Mismatched Unrelated Donor Bone Marrow Transplantation With Post-Transplantation Cyclophosphamide

Chronic Lymphocytic Leukemia (CLL) | Myelodysplastic Syndrome (MDS) | Acute Myelogenous Leukemia (AML) | Chemotherapy-sensitive Lymphoma | Acute Lymphoblastic Leukemia (ALL)/T Lymphoblastic Lymphoma | Acute Biphenotypic Leukemia (ABL) | Acute Undifferentiated Leukemia (AUL)

United States
University Hospital of Crete

Completed

Bortezomib in Combination With Gemcitabine and Cisplatin in Advanced or Metastatic Non-Small Cell Lung Cancer

Non Small Cell Lung Cancer | Metastatic

Greece
Novartis

Completed

Efficacy and Safety of Combination Therapy of Aliskiren/Amlodipine or Aliskiren/Amlodipine/Hydrochlorothiazide in Patients With Stage II Hypertension (ACADEMY)

Stage II Hypertension

Thailand
G.Gennimatas General Hospital

Unknown

Colchicine in ST-elevation Myocardial Infarction

Acute Myocardial Infarction

Greece
Fujian Cancer Hospital

Not yet recruiting

A Study to Evaluate Lenvatinib Plus Tislelizumab for Locally Advanced Unresectable or Metastatic Hepatocellular Carcinoma With Hepatitis B Virus Infection and Biomarker Analyses

Hepatocellular Carcinoma
Celgene

Completed

Phase 1 Clinical Trial of NPI-0052 in Patients With Advanced Malignancies

Advanced Cancer

Australia
Tufts University
Corporacion Ecuatoriana de Biotecnologia

Completed

Vitamin A and Zinc: Prevention of Pneumonia (VAZPOP) Study

Pneumonia | Diarrhea | Acute Upper Respiratory Tract Infections

United States, Ecuador
Boehringer Ingelheim

Completed

LUX-Lung 4: BIBW 2992 (Afatinib) Phase I Trial in Advanced Non Small Cell Lung Cancer Patients & Phase II Trial in Non Small Cell Lung Cancer Patients Failing Erlotinib or Gefitinib

Carcinoma, Non-Small-Cell Lung

Japan
Eli Lilly and Company

Completed

A Study for Treatment of Pain in Patients With Diabetic Neuropathy.

Diabetic Neuropathy, Painful

Mexico, United States, Puerto Rico
National and Kapodistrian University of Athens

Recruiting

Cortisol Circadian Rhythm in Patients With RA (CortRyRA)

Rheumatoid Arthritis

Greece
Chulalongkorn University

Recruiting

Effects of Lemborexant as a Treatment for Moderate-to-severe OSA Patients With Low Arousal Threshold (LOSALAT)

OSA

Thailand
Pfizer

Completed

Study to Assess Pharmacokinetics, Safety and Tolerability of PF-04965842 in Chinese Healthy Participants

HEALTHY

China
Medical University of Vienna

Completed

Intravenous Silibinin in Combination With Peg-interferon and Ribavirin in Nonresponders (NRSily)

Hepatitis C

Austria
Centre Hospitalier Universitaire de Saint Etienne
GlaxoSmithKline

Completed

Prospective, Multicentre, Open-label Study Evaluating 1.5 mg/Day of Fondaparinux. (PROPICE)

Major Orthopaedic Surgery and Renal Impairment

France
Chinese University of Hong Kong

Recruiting

Colchicine Use in Intracranial Atherosclerotic Disease

ICAD - Intracranial Atherosclerotic Disease

Hong Kong
University of Toronto
Canadian Institutes of Health Research (CIHR)

Completed

The Nitrate and Bone Study: Effects of Nitrates on Osteoporosis

Osteoporosis

Canada
University Hospital, Grenoble

Terminated

Evaluation of Desensitization Protocols in HLA-incompatible Kidney-transplant Candidates

Kidney Transplantation | End-stage Renal Disease | Hla-incompatible Kidney Transplant Candidates

France
Rush University Medical Center

Completed

Aprepitant- and Olanzapine- Containing Anti-emetic Regimens With High Dose Melphalan

Nausea | Vomiting

United States
Albert Einstein College of Medicine
Jacobi Medical Center

Terminated

Low Dose Aprepitant for Patients Receiving Carboplatin

Chemotherapy-induced Nausea and Vomiting

United States
Hamamatsu University

Completed

The Efficacy of Three Months-prednisolone Therapy for Chronic Eosinophilic Pneumonia

Chronic Disease | Eosinophilic Pneumonia

Japan
National Taiwan University Hospital
National Science Council, Taiwan

Unknown

Entecavir and Pegasys Sequential Therapy Versus Pegasys for HBeAg Positive Chronic Hepatitis B

Hepatitis B, Chronic

Taiwan
University of Wisconsin, Madison
National Institute on Aging (NIA)

Recruiting

Everolimus Aging Study (EVERLAST)

Insulin Resistance | Aging

United States
Merck Sharp & Dohme LLC
Pfizer

Completed

A Study to Evaluate the Efficacy and Safety of Ertugliflozin in Asian Participants With Type 2 Diabetes and Inadequate Glycemic Control on Metformin Monotherapy (MK-8835-012)

Type 2 Diabetes Mellitus
MorphoSys AG
Clinigen Healthcare Ltd

Approved for marketing

Expanded Access Program for Tafasitamab (MOR00208) in R/R DLBCL

DLBCL
University of Pavia
IRCCS Policlinico S. Matteo

Unknown

Triple Therapy in Type 2 Diabetic Patients

Type 2 Diabetes Mellitus

Italy
Huashan Hospital

Enrolling by invitation

Amphotericin B for Non-HIV Cryptococcal Meningitis Patients (ABNCM)

Antifungal Agents | Cryptococcal Meningitis

China
Boehringer Ingelheim

Completed

Telmisartan80/HCTZ25 Versus Telmisartan80/HCTZ12.5 in Hypertension Not Responding to Telmisartan80/HCTZ12.5

Hypertension

France, Switzerland, Italy, Germany, Hong Kong, Netherlands, South Africa, Spain, Taiwan, Denmark, Sweden, Finland, Ireland, Korea, Republic of, Malaysia, Norway
Khyber Medical University Peshawar

Completed

Effects of Combined Resveratrol and Myo-inositol on Altered Metabolic, Endocrine Parameters and Perceived Stress in Patients With Polycystic Ovarian Syndrome

PCOS

Pakistan
Assistance Publique - Hôpitaux de Paris
Hoffmann-La Roche

Completed

Rituximab in Auto-Immune Hemolytic Anemia (RAHIA)

Warm Autoimmune Hemolytic Anemia

France
Korea University
Gilead Sciences

Completed

Tenofovir Disoproxil Fumarate vs. Entecavir in Chronic Hepatitis B Patients With Partial Virologic Response to Entecavir (STEEP)

Chronic Hepatitis B

Korea, Republic of
Eyegate Pharmaceuticals, Inc.

Completed

OPEN-LABEL, MULTI-CENTER, PHASE 1b/2a CLINICAL TRIAL DESIGNED TO EVALUATE THE SAFETY AND EFFICACY OF IONTOPHORETIC DEXAMETHASONE PHOSPHATE OPHTHALMIC SOLUTION IN PATIENTS HAVING UNDERGONE CATARACT SURGERY WITH IMPLANTATION OF A POSTERIOR CHAMBER INTRAOCULAR LENS (IOL)

Patients Having Undergone Unilateral Cataract Extraction and Implantation of a Monofocal

United States
Dr. J. Curtis Nickel
University of California, Los Angeles; The Cleveland Clinic

Terminated

JALYN for Benign Prostatic Hyperplasia (BPH) and Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)

Benign Prostatic Hyperplasia | Chronic Prostatitis

Canada
University of Sao Paulo General Hospital
Fundação de Amparo à Pesquisa do Estado de São Paulo

Unknown

Colchicine for Patients With Chagas´ Disease( B1 Stage) (COACH)

Chagas Disease | Colchicine Resistance

Brazil
Catholic University of the Sacred Heart

Unknown

Carboplatin-Paclitaxel ± Bevacizumab in Advanced (Stage III-IV) or Recurrent Endometrial Cancer (MITOBEVAEND2)

Stage III-IV or Recurrent Endometrial Cancer

Italy
Assistance Publique - Hôpitaux de Paris
Novartis

Completed

Evaluation of Low Dose Corticosteroids Efficiency, Associated With Myfortic ® in the Treatment of Nephrotic Syndrome (MSN)

Nephrotic Syndrome

France
Merck Sharp & Dohme LLC
Pfizer

Completed

Ertugliflozin and Sitagliptin Co-administration Factorial Study (VERTIS FACTORAL, MK-8835-005)

Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC

Completed

Safety, Tolerability, and Efficacy of MK-7655 (Relebactam) + Imipenem/Cilastatin Versus Imipenem/Cilastatin Alone for Treating Complicated Urinary Tract Infection (cUTI) (MK-7655-003)

Urinary Tract Infections | Pyelonephritis
Wake Forest University Health Sciences
National Heart, Lung, and Blood Institute (NHLBI)

Completed

The Estrogen Replacement and Atherosclerosis Trial ; Primary Outcome Measure is Mean Minimal Coronary Artery Diameter After Avg of 3.2 Yrs. (ERA)

Heart Disease

United States
Postgraduate Institute of Medical Education and...

Completed

Role of Midodrine and Tolvaptan in Patients With Cirrhosis With Refractory or Recurrent Ascites

Cirrhosis | Refractory/Recurrent Ascites

India
Merck Sharp & Dohme LLC
Pfizer

Completed

Safety and Efficacy of Ertugliflozin in the Treatment of Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin and Sitagliptin (MK-8835-006; VERTIS SITA2)

Type 2 Diabetes Mellitus
Mansoura University

Completed

Aromatase Inhibitors or GnRH-a for Uterine Adenomyosis

the Efficacy of Aromatase Inhibitor vs. Gonadotrpins Releasing Hormone Agonists in Treating Premenopausal Women With Uterine Adenomyosis

Egypt
Mansoura University

Completed

Antioxidants and Zinc Improving Minimal Hepatic Encephalopathy In Truck Drivers; a Pilot Study

Minimal Hepatic Encephalopathy

Egypt
Medical University of South Carolina
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Aripiprazole Effects on Alcohol Reactivity and Consumption

Alcohol Dependence

United States
ANRS, Emerging Infectious Diseases
University of Bordeaux; PACCI Program

Unknown

Combination Therapies to Reduce Carriage of SARS-Cov-2 and Improve Outcome of COVID-19 in Ivory Coast: a Phase Randomized IIb Trial (INTENSE-COV)

COVID-19 | Severe Acute Respiratory Syndrome Coronavirus 2 | COVID-19 Drug Treatment

Côte D'Ivoire

Search clinical trials for: 1.5 mg PF-06649751 21 Days

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Denmark

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations